Spiral Therapeutics Welcomes New Investment, Cementing Its Leadership in Neurotology ...Middle East

PR Newswire - News
Spiral Therapeutics Welcomes New Investment, Cementing Its Leadership in Neurotology
Investment led by Esperante Ventures and Ferring Ventures: Additional funding to support expanded SPT-2101 clinical trial. Progress with SPT-2101 for Meniere's Disease: Encouraging data from the Australian clinical trial validates Spiral's proprietary drug delivery platform, with plans to...

Hence then, the article about spiral therapeutics welcomes new investment cementing its leadership in neurotology was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Spiral Therapeutics Welcomes New Investment, Cementing Its Leadership in Neurotology )

Apple Storegoogle play

Last updated :

Also on site :